Applied DNA Sciences Inc Stock OTC Bulletin Board
Equities
US03815U1025
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 5.02M 6.86M | Sales 2025 * | 8.17M 11.17M | Capitalization | 3.77M 5.15M |
---|---|---|---|---|---|
Net income 2024 * | -12M -16.4M | Net income 2025 * | -13M -17.77M | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.46 x |
P/E ratio 2024 * |
-0.34
x | P/E ratio 2025 * |
-0.41
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.56% |
Latest transcript on Applied DNA Sciences Inc
Managers | Title | Age | Since |
---|---|---|---|
James Hayward
CEO | Chief Executive Officer | 71 | 05-09-27 |
Beth Jantzen
DFI | Director of Finance/CFO | 47 | 13-04-30 |
Lawrence Jung
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yacov Shamash
BRD | Director/Board Member | 74 | 06-03-16 |
Bob Catell
BRD | Director/Board Member | 87 | 16-10-06 |
James Hayward
CEO | Chief Executive Officer | 71 | 05-09-27 |
1st Jan change | Capi. | |
---|---|---|
+1.69% | 12.8B | |
-7.57% | 7.61B | |
+3.22% | 5.41B | |
+0.93% | 4.51B | |
+8.42% | 4.49B | |
+9.21% | 2.73B | |
-13.87% | 2.02B | |
-11.63% | 1.73B | |
+1.99% | 1.64B |